Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dopamine D3 Receptor Heteromerization: Implications for Neuroplasticity and Neuroprotection
Federica Bono, Veronica Mutti, Chiara Fiorentini, et al.
Biomolecules (2020) Vol. 10, Iss. 7, pp. 1016-1016
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

N6-methyladenosine and Neurological Diseases
Nan Zhang, Chunhong Ding, Yuxin Zuo, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 3, pp. 1925-1937
Closed Access | Times Cited: 100
Immunomodulatory Effects of Dopamine in Inflammatory Diseases
Yifei Feng, Yan Lü
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 71
Dopamine D1–D5 Receptors in Brain Nuclei: Implications for Health and Disease
K. Kawahata, David I. Finkelstein, Kohji Fukunaga
Receptors (2024) Vol. 3, Iss. 2, pp. 155-181
Open Access | Times Cited: 12
Restoration and targeting of aberrant neurotransmitters in Parkinson's disease therapeutics
Divya Yadav, Pravir Kumar
Neurochemistry International (2022) Vol. 156, pp. 105327-105327
Closed Access | Times Cited: 32
Cognitive Deficit in Schizophrenia: From Etiology to Novel Treatments
Antón L. Martínez, José Brea, Sara Rico, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 9905-9905
Open Access | Times Cited: 34
The oxytocin receptor represents a key hub in the GPCR heteroreceptor network: potential relevance for brain and behavior
Dasiel O. Borroto‐Escuela, Cristina Cuesta‐Marti, Alexander López‐Salas, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 21
Risperidone Decreases Expression of Serotonin Receptor-2A (5-HT2A) and Serotonin Transporter (SERT) but Not Dopamine Receptors and Dopamine Transporter (DAT) in PBMCs from Patients with Schizophrenia
Samantha Álvarez-Herrera, Mauricio Rosel-Vales, Gilberto Pérez‐Sánchez, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 167-167
Open Access | Times Cited: 4
Role of dopamine receptor heteromerization in preclinical models of addiction and other psychiatric disorders
Adèle Vilette, Anna Petitbon, Marie‐Charlotte Allichon, et al.
Exploration of Neuroprotective Therapy (2025) Vol. 5
Open Access
Exploring the underlying mechanisms of drug‐induced impulse control disorders: a pharmacovigilance‐pharmacodynamic study
Michele Fusaroli, Valentina Giunchi, Vera Battini, et al.
Psychiatry and Clinical Neurosciences (2022) Vol. 77, Iss. 3, pp. 160-167
Open Access | Times Cited: 16
Advances in small molecule selective ligands for heteromeric nicotinic acetylcholine receptors
Carlo Matera, Claudio Papotto, Clelia Dallanoce, et al.
Pharmacological Research (2023) Vol. 194, pp. 106813-106813
Open Access | Times Cited: 10
Cariprazine in the acute treatment of unipolar and bipolar depression: A systematic review and meta-analysis
João Martins-Correia, Luís Afonso Fernandes, Ryan Kenny, et al.
Journal of Affective Disorders (2024) Vol. 362, pp. 297-307
Open Access | Times Cited: 3
Neuroprotection afforded by targeting G protein-coupled receptors in heteromers and by heteromer-selective drugs
Rafael Franco, Gemma Navarro
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
Pramipexole improves depression-like behavior in diabetes mellitus with depression rats by inhibiting NLRP3 inflammasome-mediated neuroinflammation and preventing impaired neuroplasticity
Ping Li, Tingting Wang, Haipeng Guo, et al.
Journal of Affective Disorders (2024) Vol. 356, pp. 586-596
Closed Access | Times Cited: 2
Impaired dopamine D3 and nicotinic acetylcholine receptor membrane localization in iPSCs-derived dopaminergic neurons from two Parkinson’s disease patients carrying the LRRK2 G2019S mutation
Federica Bono, Veronica Mutti, Paola Devoto, et al.
Neurobiology of Aging (2020) Vol. 99, pp. 65-78
Closed Access | Times Cited: 20
Disrupting GPCR Complexes with Smart Drug-like Peptides
Maria Gallo, Sira Defaus, David Andreu
Pharmaceutics (2022) Vol. 14, Iss. 1, pp. 161-161
Open Access | Times Cited: 11
Neurobiological and Pharmacological Perspectives of D3 Receptors in Parkinson’s Disease
Abdeslam Chagraoui, Giuseppe Di Giovanni, Philippe De Deurwaerdère
Biomolecules (2022) Vol. 12, Iss. 2, pp. 243-243
Open Access | Times Cited: 11
Structural Plasticity of Dopaminergic Neurons Requires the Activation of the D3R-nAChR Heteromer and the PI3K-ERK1/2/Akt-Induced Expression of c-Fos and p70S6K Signaling Pathway
Veronica Mutti, Federica Bono, Zaira Tomasoni, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 4, pp. 2129-2149
Open Access | Times Cited: 10
Insights into the Involvement and Therapeutic Target Potential of the Dopamine System in the Posttraumatic Stress Disorder
Mengnan Liu, Xiao-Yu Tian, Ting Fang, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 7, pp. 3708-3723
Closed Access | Times Cited: 5
Dopamine D3 Receptor Plasticity in Parkinson’s Disease and L-DOPA-Induced Dyskinesia
Kathryn Lanza, Christopher Bishop
Biomedicines (2021) Vol. 9, Iss. 3, pp. 314-314
Open Access | Times Cited: 10
Potential Mechanisms for Why Not All Antipsychotics Are Able to Occupy Dopamine D3 Receptors in the Brain in vivo
Béla Kiss, Balázs Krámos, I. Laszlovszky
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 6
Nicotine and menthol independently exert neuroprotective effects against cisplatin- or amyloid- toxicity by upregulating Bcl-xl via JNK activation in SH-SY5Y cells
YIBIN RUAN, ZHONGMING XIE, QIONG LIU, et al.
Biocell (2021) Vol. 45, Iss. 4, pp. 1059-1067
Open Access | Times Cited: 8
Smoking Genes: A Case–Control Study of Dopamine Transporter Gene (SLC6A3) and Dopamine Receptor Genes (DRD1, DRD2 and DRD3) Polymorphisms and Smoking Behaviour in a Malay Male Cohort
Ruzilawati Abu Bakar, Md Asiful Islam, Siti Khariem Sophia Muhamed, et al.
Biomolecules (2020) Vol. 10, Iss. 12, pp. 1633-1633
Open Access | Times Cited: 8
G Protein-Dependent Activation of the PKA-Erk1/2 Pathway by the Striatal Dopamine D1/D3 Receptor Heteromer Involves Beta-Arrestin and the Tyrosine Phosphatase Shp-2
Federica Bono, Zaira Tomasoni, Veronica Mutti, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 473-473
Open Access | Times Cited: 2
Psychosis in Parkinson’s Disease and Current Management Trends- an Updated Review of Literature
Rajib Dutta
Journal of Neuroscience and Neurological Disorders (2023) Vol. 7, Iss. 2, pp. 027-057
Open Access | Times Cited: 2
Recent Advances in Dopamine D3 Receptor Heterodimers: Focus on Dopamine D3 and D1 Receptor–Receptor Interaction and Striatal Function
Federica Bono, Veronica Mutti, Zaira Tomasoni, et al.
Current topics in behavioral neurosciences (2022), pp. 47-72
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top